echoloc
Get started
echoloc/ Companies/ Eikon Therapeutics
Company profile

Eikon Therapeutics Tech Stack

Clinical-stage oncology biopharma with imaging- and ML-driven target discovery

Biotechnology Research Millbrae, CA 201–500 employees Founded 2019 Privately Held
eikontx.com LinkedIn

Eikon Therapeutics is a Millbrae-based biopharma running late-stage oncology programs while using single-molecule imaging and machine learning to find new targets. Its stack pairs a heavy R/Posit and Databricks analytics layer with agentic AI frameworks (LangChain, LangGraph, AutoGen) and structural tools like AlphaFold and GROMACS. Senior-weighted, research-led hiring alongside an SEC Reporting Director search points to scaling clinical execution and public-company-grade finance.

Tech Stack 33 technologies

Core StackDatabricks Python C++ React TypeScript PostgreSQL C# Java SAS Tableau Pandas NumPy TensorFlow Jira LangChain HPLC-MS RStudio R Markdown Shiny tidyverse Posit RDKit Veeva ImageJ GraphPad Prism AlphaFold GROMACS LangGraph AutoGen SuccessFactors+1 more

What Eikon Therapeutics Is BuildingChallenges and projects from their job posts

◆Challenges

  • Running global clinical trials on time and budget
  • Regulatory compliance and submission management
  • Maintaining inspection readiness and quality-by-design execution
  • Ensuring continuous drug supply
  • Lack of interpretability in machine learning models
  • Identifying novel Parkinson's disease therapeutic targets

▲Active Projects

  • Target validation and mechanism-of-action assay development
  • Multimodal data analysis for experimental systems
  • Analytical approaches and proof-of-concept tools
  • Adopting novel experimental systems
  • Clinical site budgets, FMV rationale and negotiation
  • Investigational product supply project plans

Hiring Activity

Steady40 roles · 10 in 30d

Department

Research
15
Healthcare
6
Engineering
4
Ops
3
Finance
2
Operations
2
Regulatory
2
HR
1

Seniority

Senior
23
Mid
8
Director
5
Junior
1
Staff
1

Notable leadership hires: SEC Reporting Director

Companies like Eikon Therapeutics

100+ Biotechnology Research companies running Python and C++

See the full list

About Eikon Therapeutics

Eikon Therapeutics is a privately held biopharmaceutical company founded in 2019 and headquartered in Millbrae, California. Its clinical pipeline targets cancer through immune response modulation and synthetic lethality approaches. Discovery work applies single-molecule imaging to cancer and neurological disease biology, with machine learning applied to the resulting large imaging datasets. The company employs 201–500 people and hires in the United States across research, clinical, engineering, regulatory, operations and finance functions.

HeadquartersMillbrae, CA
Company Size201–500 employees
Founded2019
Hiring MarketsUnited States

Frequently Asked Questions

What tech stack does Eikon Therapeutics use?

Eikon uses Python, R (RStudio, Shiny, tidyverse, Posit), Databricks, PostgreSQL, TensorFlow, RDKit, AlphaFold, GROMACS, ImageJ, Veeva, SAS, Tableau and AI agent frameworks like LangChain and AutoGen.

Where is Eikon Therapeutics headquartered?

Eikon Therapeutics is headquartered in Millbrae, California, and currently hires in the United States.

What is Eikon Therapeutics working on?

Eikon is developing target validation and mechanism-of-action assays, analyzing multimodal experimental data, building proof-of-concept analytical tools, and managing clinical site budgets and investigational product supply.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

X
X-Chem, Inc.
Biotechnology Research
I
insitro
Biotechnology Research
D
Deep Origin
Biotechnology Research
E
Element Biosciences
Biotechnology Research

How this profile is built

Eikon Therapeutics's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.